Armata Pharmaceuticals Inc ARMP:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 01/21/22 EST
5.48quote price arrow down-0.07 (-1.26%)
Volume
50,334
52 week range
2.82 - 10.48
Loading...
  • Open5.55
  • Day High5.80
  • Day Low5.19
  • Prev Close5.55
  • 52 Week High10.48
  • 52 Week High Date01/28/21
  • 52 Week Low2.82
  • 52 Week Low Date10/28/21

Key Stats

  • Market Cap148.45M
  • Shares Out27.09M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-1.6207635395987684e-14

KEY STATS

  • Open5.55
  • Day High5.80
  • Day Low5.19
  • Prev Close5.55
  • 52 Week High10.48
  • 52 Week High Date01/28/21
  • 52 Week Low2.82
  • 52 Week Low Date10/28/21
  • Market Cap148.45M
  • Shares Out27.09M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-1.6207635395987684e-14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.10
  • P/E (TTM)-5.00
  • Fwd P/E (NTM)-6.71
  • EBITDA (TTM)-21.953M
  • ROE (TTM)-98.12%
  • Revenue (TTM)3.99M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-594.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/16/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Armata Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using bacteriophage-based technology. The Company is a developer of synthetic phage platform, which targets therapeutics for the treatment of various multidrug-resistant bacterial infections. It develops synthetic phage products that...
Brian Varnum Ph.D.
Chief Executive Officer, Director
Steven Martin
Chief Financial Officer
Mina Pastagia M.D.
Vice President - Clinical Development
Address
4503 Glencoe Ave
Marina Del Rey, CA
90292-6372
United States

Top Peers

SYMBOLLASTCHG%CHG
CLSD
Clearside Biomedical Inc
1.89-0.08-4.06%
ALGS
Aligos Therapeutics Inc
3.03-0.02-0.66%
SYBX
Synlogic Inc
1.65-0.20-10.81%
MNOV
MediciNova Inc
2.22-0.12-5.13%
BOLT
Bolt Biotherapeutics Inc
3.63-0.13-3.46%